Schizophrenia studies

Mobile technology health management for people with severe mental illness

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

East London NHS Foundation Trust

Optimising AVATAR therapy for distressing voices

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

King's College London (University)

Optimising individualised prescribing with therapeutic drug Monitoring for Antipsychotics (OptIMA) 2: clinical study of antipsychotic drug level monitoring

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Institute of Psychiatry, Kings College London (UK)

Transcranial Magnetic Stimulation (TMS) treatment study in auditory verbal hallucinations

This study isn't currently recruiting.

Countries

Switzerland

Sponsor

Swiss National Fund (Switzerland)

Worry & persecutory delusions: a brief group intervention

This study isn't currently recruiting.

Countries

United Kingdom

Sponsor

Oxleas NHS foundation Trust

A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

France, United Kingdom, Belgium, + 4 others

Sponsor

ACADIA Pharmaceuticals Inc.

A randomised, double-blind, placebo-controlled, parallel-group trial of Vitamin D supplementation compared to placebo in people presenting with their First Episode of psychosis (DFEND) Neuroprotect...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom

Sponsor

King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust

A Single center, Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Psychosis in Alzheimer’s Disease

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom

Sponsor

ACADIA Pharmaceuticals Inc

Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study-

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany

Sponsor

Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy

Pragmatic Randomised Control Trial of Quetiapine for psychosis in Parkinson’s Disease

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

United Kingdom

Sponsor

King’s College London & King’s College Hospital

Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions i...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany

Sponsor

Medical School of Hannover

The TEA Trial- Tolerance and Effect of Antipsychotics in children and adolescents with psychosis An investigator-initiated, phase IV, randomised double-blind multi-centre trial of the benefits and...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Denmark

Sponsor

University of Copenhagen